XML 17 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Marketable Securities
9 Months Ended
Sep. 30, 2014
Investments Debt And Equity Securities [Abstract]  
Marketable Securities

NOTE 3—MARKETABLE SECURITIES

Sangamo generally classifies its marketable securities as available-for-sale and records its investments at fair value. Available-for-sale securities are carried at estimated fair value, with the unrealized holding gains and losses included in accumulated other comprehensive income. Investments that have maturities beyond one year as of the end of the reporting period are classified as non-current. The Company’s investments are subject to a periodic impairment review, and the Company recognizes an impairment charge when a decline in the fair value of its investments below the cost basis is judged to be other-than-temporary. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time and extent to which the fair value has been less than the Company’s cost basis, the financial condition and near-term prospects of the investee, and the Company’s intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in the market value.

The table below summarizes the Company’s investments (in thousands):

 

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

 

Cost

 

 

Gains

 

 

(Losses)

 

 

Fair Value

 

September 31, 2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

7,193

 

 

$

 

 

$

 

 

$

7,193

 

Total

 

7,193

 

 

 

 

 

 

 

 

 

7,193

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper securities

$

36,195

 

 

$

53

 

 

$

 

 

$

36,248

 

Corporate debt securities

 

20,621

 

 

 

 

 

 

(11

)

 

 

20,610

 

U.S. government sponsored entity debt

   securities

 

163,399

 

 

 

11

 

 

 

 

 

 

163,410

 

Total

 

220,215

 

 

 

64

 

 

 

(11

)

 

 

220,268

 

Total cash equivalents and available-for-sale securities

$

227,408

 

 

$

64

 

 

$

(11

)

 

$

227,461

 

December 31, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

6,934

 

 

$

 

 

$

 

 

$

6,934

 

Total

 

6,934

 

 

 

 

 

 

 

 

 

6,934

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government sponsored entity debt

   securities

 

121,278

 

 

 

12

 

 

 

 

 

 

121,290

 

Total cash equivalents and available-for-sale

   securities

$

128,212

 

 

$

12

 

 

$

 

 

$

128,224

 

 

The Company had no other-than-temporary impairments of its investments for the three and nine months ended September 30, 2014 or the twelve months ended December 31, 2013.